Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Tumor Suppressor Roles of MYBBP1A, a Major Contributor to Metabolism Plasticity and Stemness
Blanca Felipe‐Abrio, Amancio Carnero
Cancers (2020) Vol. 12, Iss. 1, pp. 254-254
Open Access | Times Cited: 30

Showing 1-25 of 30 citing articles:

NAD+ metabolism, stemness, the immune response, and cancer
Lola E. Navas, Amancio Carnero
Signal Transduction and Targeted Therapy (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 331
Role of Mitochondria in Cancer Stem Cell Resistance
José Manuel García-Heredia, Amancio Carnero
Cells (2020) Vol. 9, Iss. 7, pp. 1693-1693
Open Access | Times Cited: 79
Genomics and transcriptomics identify quantitative trait loci affecting growth-related traits in silver pomfret (Pampus argenteus)
Cheng Zhang, Shun Zhang, Guanlin Wang, et al.
Comparative Biochemistry and Physiology Part D Genomics and Proteomics (2025) Vol. 54, pp. 101414-101414
Closed Access | Times Cited: 1
Therapeutic Targeting of Signaling Pathways Related to Cancer Stemness
Asunción Espinosa-Sánchez, Elisa Suárez-Martínez, Laura Sánchez-Díaz, et al.
Frontiers in Oncology (2020) Vol. 10
Open Access | Times Cited: 50
Integrative phosphoproteomics defines two biologically distinct groups of KMT2A rearranged acute myeloid leukaemia with different drug response phenotypes
Pedro Casado, Ana Rio‐Machín, Juho J. Miettinen, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 16
Emerging role of MYB transcription factors in cancer drug resistance
Bernhard Biersack, Michael Höpfner
Cancer Drug Resistance (2024)
Open Access | Times Cited: 5
Biological effects and regulation of IGFBP5 in breast cancer
Jürgen Dittmer
Frontiers in Endocrinology (2022) Vol. 13
Open Access | Times Cited: 22
OCTN2 enhances PGC-1α-mediated fatty acid oxidation and OXPHOS to support stemness in hepatocellular carcinoma
Tao Yang, Ning Liang, Jiahao Zhang, et al.
Metabolism (2023) Vol. 147, pp. 155628-155628
Closed Access | Times Cited: 12
Nuclear Actin Polymerization Regulates Cell Epithelial‐Mesenchymal Transition
William W. Du, Javeria Qadir, Kevin Y. Du, et al.
Advanced Science (2023) Vol. 10, Iss. 28
Open Access | Times Cited: 10
Proteomic Characterization of NEDD4 Unveils Its Potential Novel Downstream Effectors in Gastric Cancer
Jisoo Han, Yoonhee Shin, Eunjung Kim, et al.
Journal of Proteome Research (2025)
Closed Access
A fetal tumor suppressor axis abrogates MLL-fusion-driven acute myeloid leukemia
Mohamed Eldeeb, Ouyang Yuan, Nicola Guzzi, et al.
Cell Reports (2023) Vol. 42, Iss. 2, pp. 112099-112099
Open Access | Times Cited: 9
Combined genomic and proteomic approaches reveal DNA binding sites and interaction partners of TBX2 in the developing lung
Timo H. Lüdtke, Irina Wojahn, Marc‐Jens Kleppa, et al.
Respiratory Research (2021) Vol. 22, Iss. 1
Open Access | Times Cited: 17
Deciphering the Impact of Rare Missense Variants in EGFR-TKI-Resistant Non-Small-Cell Lung Cancer through Whole Exome Sequencing: A Computational Approach
Ambritha Balasundaram, C. George Priya Doss
ACS Omega (2024) Vol. 9, Iss. 14, pp. 16288-16302
Open Access | Times Cited: 2
From metabolism to malignancy: the multifaceted role of PGC1α in cancer
Yue Wang, Jianing Peng, Dengyuan Yang, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 2
Tibetan medicine Liuwei Muxiang pills (LWMX pills) effectively protects mice from chronic non-atrophic gastritis
Rinchen Dhondrup, Tawni Tidwell, XiaoKang Zhang, et al.
Phytomedicine (2023) Vol. 115, pp. 154826-154826
Open Access | Times Cited: 5
Hbo1 and Msl complexes preserve differential compaction and H3K27me3 marking of active and inactive X chromosomes during mitosis
Dounia Djeghloul, Sherry Cheriyamkunnel, Bhavik Anil Patel, et al.
Research Square (Research Square) (2024)
Closed Access | Times Cited: 1
Are Genetic Modifiers the Answer to Different Responses to Hydroxyurea Treatment?—A Pharmacogenetic Study in Sickle Cell Anemia Angolan Children
Catarina Ginete, Mariana Delgadinho, Brígida Santos, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 10, pp. 8792-8792
Open Access | Times Cited: 3
Growth of pancreatic cancers with hemizygous chromosomal 17p loss of MYBBP1A can be preferentially targeted by PARP inhibitors
Antony Hsieh, Jason R. Pitarresi, Jonathan Lerner, et al.
Science Advances (2020) Vol. 6, Iss. 49
Open Access | Times Cited: 6
Insights into Asparaginase Allergic Responses: Exploring Pharmacogenetic Influences
Daiane Keller Cecconello, Klerize Anecely de Souza Silva, Evelin Cristine Mendonça de Senna, et al.
Pharmaceutics (2024) Vol. 16, Iss. 9, pp. 1134-1134
Open Access
Non‐immune hydrops fetalis is associated with bi‐allelic pathogenic variants in the MYB Binding Protein 1a (MYBBP1A) gene
Jair Tenorio, Elena Mansilla Aparicio, Fe Amalia García Santiago, et al.
Clinical Genetics (2024) Vol. 106, Iss. 6, pp. 713-720
Open Access
A Prognostic Model for Prostate Cancer Patients Based on Two DNA Damage Response Mutation-Related Immune Genes
Jian Wang, Jiang Li, Zhenhua Shang, et al.
Cancer Biotherapy and Radiopharmaceuticals (2023) Vol. 39, Iss. 4, pp. 306-317
Closed Access | Times Cited: 1
Regulation of phosphosignaling pathways involved in transcription of cell cycle target genes by TRH receptor activation in GH1 cells
Zdeňka Drastichová, Radka Trubacova, Jiřı́ Novotný
Biomedicine & Pharmacotherapy (2023) Vol. 168, pp. 115830-115830
Open Access | Times Cited: 1
In vivo protein turnover rates in varying oxygen tensions nominate MYBBP1A as a mediator of the hyperoxia response
Xuewen Chen, Augustinus G. Haribowo, Alan H. Baik, et al.
Science Advances (2023) Vol. 9, Iss. 49
Open Access | Times Cited: 1
Identification and validation of the clinical prediction model and biomarkers based on chromatin regulators in colon cancer by integrated analysis of bulk- and single-cell RNA sequencing data
Yichao Ma, Fang Fang, Kai Liao, et al.
Translational Cancer Research (2024) Vol. 13, Iss. 3, pp. 1290-1313
Open Access
Development of biomarker signatures associated with anoikis to predict prognosis in patients with esophageal cancer: An observational study
Yunwei Liang, Xin Yin, Yinhui Yao, et al.
Medicine (2024) Vol. 103, Iss. 40, pp. e39745-e39745
Open Access
Page 1 - Next Page

Scroll to top